East Hills, NY (March 19, 2007) - - Disposable technologies are helping pharmaceutical manufacturers maintain high levels of sterility and meet mounting pressure to improve the speed, safety and economics of vaccine production. Critical to effective single-use processing operations are aseptic connection devices. Pharmaceutical manufacturers typically make about 25,000 aseptic connections each year, with some large manufacturers making as many as 100,000 aseptic connections annually. Pall Corporation (NYSE: PLL), the pioneer in providing single-use technologies to the biopharmaceutical industry, is expanding its line of Kleenpak™ Aseptic Connectors with two new sizes, 1/4- and 3/8-inch. The new sizes enable vaccine manufacturers to apply the safety and efficiency benefits of instant aseptic connections throughout more of their disposable operations to help speed time to market and comply with good manufacturing practices.
